SCLN
Sciclone Pharmaceuticals Inc
SCLN
SCLN
Delisted
SCLN was delisted on the 13th of October, 2017.
96 hedge funds and large institutions have $122M invested in Sciclone Pharmaceuticals Inc in 2014 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 33 increasing their positions, 40 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
90% less call options, than puts
Call options by funds: $15K | Put options by funds: $146K
Holders
96
Holding in Top 10
–
Calls
$15K
Puts
$146K
Top Buyers
| 1 | +$1.03M | |
| 2 | +$671K | |
| 3 | +$607K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$367K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$329K |
Top Sellers
| 1 | -$2.21M | |
| 2 | -$1.68M | |
| 3 | -$1.66M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.12M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.01M |